Staar Surgical Board Authorizes $50 Million Share Repurchase Program
Question
Staar Surgical Board Authorizes $50 Million Share Repurchase Program
Direct answer
Execution of the $50 million repurchase reduces outstanding float, directly increasing earnings per share accretion. — bullish pressure on STAA via float reduction and capital allocation support.
- Original publisher
- Market Ontology
- Evidence through
- 2026-09-27
- Published
- 2026-10-20
- Revision
- 1 · 2026-10-20
Cite as: Market Ontology, “Staar Surgical Board Authorizes $50 Million Share Repurchase Program”, revision 1, evidence through 2026-09-27. https://marketontology.com/catalysts/2026-09-27/staar-surgical-board-authorizes-50-million-share-repurchase-program-e82982
| Asset | Direction | Timeframe | Channel | Score |
|---|---|---|---|---|
| STAA | ▲Bull | 1–4 weeks | float reduction and capital allocation support | 62 |
Staar Surgical Board Authorizes $50 Million Share Repurchase Program
Execution of the $50 million repurchase reduces outstanding float, directly increasing earnings per share accretion. — bullish pressure on STAA via float reduction and capital allocation support.
Source explicitly confirms $50M buyback authorization and 7.5% stock reaction.
- SourceSource explicitly confirms $50M buyback authorization and 7.5% stock reaction.
- TransmissionExecution of the $50 million repurchase reduces outstanding float, directly increasing earnings per share accretion.
- SummarySTAA authorized a $50 million common stock repurchase program. Shares rallied 7.5% during Friday's trading session. Management cited balance sheet cash reserves and discounted valuation.
- STAADirect directional exposure
Illustrative, not advice
- Crowded positioning may already reflect the move
- Counter-catalyst could neutralize the thesis before window closes
- STAA closes below pre-catalyst level on rising volume
- Catalyst narrative is officially walked back or contradicted
- Cross-asset confirmation (rates / FX / vol) reverses direction
- STAA price vs. pre-event level
- STAA volume vs. 20-day average
What happened next
| Asset | Call | Base close | +1 day | +5 days | +20 days |
|---|---|---|---|---|---|
| STAA | Bullishagreed | 20.51 2026-09-25 | +1.76% | +9.56% | Pending |
Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.
Sources
- Why Staar Surgical Stock Soared Today · Polygon News · 2026-09-25
Related catalysts
- 2026-09-30Staar Surgical Rallies 8% Following Stifel Upgrade to Buy and $31 TargetSF STAA-1.11%
- 2026-09-30Staar Surgical Rallies 8% on Stifel Rating Upgrade and Higher Price TargetSTAA-1.11%
- 2026-09-30Staar Surgical Rallies 8% on Stifel Rating Upgrade and Higher Price TargetSTAA-1.11%
- 2026-09-30Staar Surgical Rallies 8% on Stifel Upgrade and Lens Demand OutlookSTAA-1.11%
- 2026-09-27Staar Surgical Board Authorizes $50 Million Share Repurchase ProgramSTAA+9.56%
- 2026-09-27Staar Surgical Rallies 7.5% Following Board Approval of $50 Million Buyback ProgramSTAA+9.56%
- 2026-09-27Staar Surgical Rallies 7.5% Following Board Approval of $50 Million Buyback ProgramSTAA+9.56%
- 2026-09-27Staar Surgical Board Authorizes $50 Million Share Repurchase ProgramSTAA+9.56%
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.